pk 11195 has been researched along with Recrudescence in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Airas, L; Matilainen, M; Nylund, M; Polvinen, E; Rissanen, E; Rokka, J; Sucksdorff, M; Tuisku, J; Vuorimaa, A | 1 |
| Mendonça-Torres, MC; Roberts, SS | 1 |
| Achten, E; De Reuck, JL; De Vos, F; Debruyne, JC; Dierckx, RA; Keppens, J; Korf, J; Slegers, G; Strijckmans, K; Van Laere, KJ; Versijpt, J | 1 |
3 other study(ies) available for pk 11195 and Recrudescence
| Article | Year |
|---|---|
Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis.
Topics: Adult; Brain; Cohort Studies; Disability Evaluation; Disease Progression; Female; Humans; Isoquinolines; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Positron-Emission Tomography; Predictive Value of Tests; Radioligand Assay; Receptors, GABA; Recurrence; White Matter | 2020 |
The translocator protein (TSPO) ligand PK11195 induces apoptosis and cell cycle arrest and sensitizes to chemotherapy treatment in pre- and post-relapse neuroblastoma cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP-Binding Cassette Transporters; Carboplatin; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Etoposide; Humans; Isoquinolines; Ligands; Melphalan; Neuroblastoma; Receptors, GABA; Recurrence; RNA, Messenger | 2013 |
PET visualization of microglia in multiple sclerosis patients using [11C]PK11195.
Topics: Adult; Age Factors; Antineoplastic Agents; Brain Mapping; Cohort Studies; Female; Humans; Isoquinolines; Magnetic Resonance Imaging; Male; Microglia; Middle Aged; Multiple Sclerosis; Parietal Lobe; Radioligand Assay; Recurrence; Thalamus; Tomography, Emission-Computed | 2003 |